| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-19 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |